Skip to content
MarketScale
‹ Back to IndustriesHealthcare

An App Could Change How Obesity is Assessed

The idea that something still widely used in the medical world is outdated is an unnerving thought. However, such is the case with the Body Mass Index (BMI), although this appears to be coming to an end. After more than a decade of research, Richard Barnes, CEO of Malvern, England-based Select Research and partners…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The idea that something still widely used in the medical world is outdated is an unnerving thought. However, such is the case with the Body Mass Index (BMI), although this appears to be coming to an end.

After more than a decade of research, Richard Barnes, CEO of Malvern, England-based Select Research and partners at the Mayo Clinic in the U.S. have unveiled an antidote to the 1830s measurement tool that is BMI.

Mayo Clinic Research Associate Dr. Jose Medina-Inojosa, M.D. and Barnes believe Body Volume Index (BVI) is a much better determinant of whether someone is at risk for cardiovascular diseases and diabetes.

“[BMI] is not the complete picture and it’s designed for population statistics. So, for it to be used for an individual assessment of risk is, I believe, inappropriate,” Barnes said. “Yet, to be fair, there hasn’t been anything else available until now.”

What Barnes is calling Body Volume Indicator takes an individual person’s body and measures weight in seven segments as opposed to simply height and weight. This should better determine how at-risk an individual is, giving doctors a clearer course of action and potentially saving clients money on premiums.

The progression of personal technology has been critical to this innovation. Users have photos taken of themselves on a smart device and the software analyzes the images. People have become much more comfortable with this as technology has become a larger part of daily life in the past 10 years, according to Barnes.

“I can’t stress strongly enough the smartphone has allowed us to deliver that in a way we weren’t able to before,” Barnes said. “BMI is just height and weight and that simplicity always meant people had an excuse not to migrate to something else.”

Dr. Medina said the development will help hospitals integrate data on specific patients to the electronic health record system and support the growing field of telemedicine.

“I’m very hopeful this will ease the workload and help the actual face-to-face interactions between the practitioner and the patient,” he said.

The BVI app is currently available in the app store on Android and iOS to provide a demonstration. In the coming months the goal is that a number can be associated with pictures to appropriately assess risk.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Wearables, AI diagnostics, and cybersecurity converge as healthcare's operational pressure points in 2026

Wearables, AI diagnostics, and cybersecurity converge as healthcare's operational pressure points in 2026

Wearable technology, AI diagnostics, and cybersecurity are becoming critical operational areas in healthcare by 2026. Companies like Samsung and GE HealthCare are advancing in these fields with new technologies, while cybersecurity incidents like the AnMed attack highlight the vulnerabilities in health systems. Healthcare providers must prioritize innovation and security to adapt to these emerging challenges.

  • 01Samsung's FDA-cleared Galaxy Ring represents an advancement in wearable health technology.
  • 02GE HealthCare has introduced a new AI-enabled ultrasound system.
  • 03The AnMed cyberattack underscores the urgent need for robust cybersecurity measures in healthcare.

Aug 13, 2026

TSP: Yvonne Commodore-Mensah

TSP: Yvonne Commodore-Mensah

The article discusses topics within the healthcare industry, focusing on contributions and insights from professionals in the field. It may delve into innovative practices or emerging trends shaping the sector. The discussion could also include expert opinions and potential strategies for improvement.

Aug 13, 2026

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

Generative AI is accelerating drug discovery processes, significantly reducing timelines from years to mere months. Clinical operators must adapt to this rapid change as AI-designed solutions become integral to the healthcare pipeline.

  • 01Generative AI is capable of reducing drug discovery timelines from years to months.
  • 02The integration of AI into healthcare is necessitating changes in clinical operations.
  • 03AI-informed patients are becoming more common in clinical settings.

Aug 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512